Every night, the online Belgian patent register ('eRegister') receives an update with public data that were entered or generated the preceding day on the Benelux Patent Platform, the computer application with which the Belgian Intellectual Property Office handles the registration, treatment and publication processes for patents and supplementary protection certificates.
Currently, some updates are spread over consecutive nights due to the large, weekly volume of data concerning European patents designating Belgium.
For a European patent it is possible that data about the inventor(s) are missing from the online Belgian patent register. They can be found via the link to the European patent register pending an update of the Belgian patent register.
For European patents with Unitary Effect, the authentic source of information is the European Patent Register : please refer to it.

Patent details

2542236 Title: KOMBINATION ENTHALTEND 6-BENZYLPHENYL-2-SULFURTERAHYDROPYRAN-3,4,5-TRIOLDERIVATE ALS HEMMER DER NATRIUM-GLUCOSE-COTRANSPORTER 1 UND 2 ZUR VERWENDUNG BEI DIABETESPATIENTEN

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic information

Application number:
117073247
WO application number:
US2011026591
Type:
European patent granted for BE
Status:
Open
Publication number:
2542236
WO publication number:
WO2011109333
1rst applicant's nationality:
Translation language:
German
EPO publication language:
English
SPC number:

Dates

Filing date:
01/03/2011
Grant date:
26/10/2016
EP publication date:
09/01/2013
WO publication date:
09/09/2011
Claims translation received date:
Translation received date (EP publication B1):
18/01/2017
Translation received date (EP publication B2):
Translation received date (EP publication B3):
Registration date:
26/10/2016
EP B1 publication date:
26/10/2016
EP B2 publication date:
EP B3 publication date:
Lapsed date:
Expiration date (if granted and all annual fees paid):
01/03/2031

Applicant

Name:
Lexicon Pharmaceuticals, Inc.
Legal Form:
From:
26/10/2016
Address:
8800 Technology Forest Place, The Woodlands, TX 77381, United States (US)
To:

Agent

Name:
CHIELENS Kristof
Legal Form:
From:
18/01/2017
Address:
Pres. Kennedypark 31c, 8500, KORTRIJK, Belgium (BE)
To:

Inventor

1

Name:
BROWN, Philip Manton
Legal Form:
Address:
Dallas TX 75205, United States (US)

2

Name:
FREIMAN, Joel Philip
Legal Form:
Address:
The Woodlands Texas 77381, United States (US)

3

Name:
POWELL, David Reed
Legal Form:
Address:
Houston Texas 77096, United States (US)

Priority

Priority patent number:
309592 P
Priority date:
02/03/2010
Priority country:
United States (US)

Classification

IPC or IDT classification:
A61K 31/351; A61P 9/00;

Publication

Bulletin

Bulletin heading:
EP3
Journal edition number:
2017/01a
Publication date:
16/09/2019
Description:
Contains data concerning European patents granted for Belgium and published (B1 publication) in English and for which a translation in Dutch, French or German was filed under the Belgian Patent Laws

European Patent Bulletin

Issue number:
201643
Publication date:
26/10/2016
Description:
Grant (B1)

Annual fee

Annual fee(s) Due Date:
31/03/2027
Annual fee number:
17
Annual fee amount:
450 Euro
Expected payer:
Last annual fee payment date:
16/02/2026
Last annual fee paid number:
16
Last annual fee paid amount:
400 Euro
Payer:
C.P.A.
Filing date Document type Publication Type Document Description Number of pages File Type
18/01/2017 General Document Other 1 PDF /3/2/2/5/5/0721555223/docs/117073247_0_generaldocument_20170119_082444930.pdf
18/01/2017 Translations 54 PDF /3/2/2/5/5/0721555223/docs/117073247_1_translations_20170119_082440136.pdf
18/01/2017 Incoming Correspondence (Email) Cover letter 1 PDF /3/2/2/5/5/0721555223/docs/117073247_2_incomingcorrespondenceelectronic_20170119_082445642.pdf